Lyell Immunopharma, Inc. (LYEL) Earnings
|
Expand Research on LYEL
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +47.5% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -1.1% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/6/25  |
Q225 | N/A | -$0.16 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/13/25 |
Q125 | N/A | -$0.17 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/14/25 |
Q125 | N/A | -$0.17 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/3/25 |
Q424 | N/A | -$0.19 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 2/27/25 |
Q424 | N/A | -$0.19 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 2/28/25 |
Q424 | N/A | -$0.19 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 2/26/25 |
Q424 | N/A | -$0.19 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/4/25 |
Q424 | N/A | -$0.19 | N/A | N/A | N/A | N/A | N/A | N/A |
